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Selectins play a central role in leukocyte traffickingby
mediating tethering and rolling on vascular surfaces.
Here we have reported that T cell immunoglobulin
and mucin domain 1 (TIM-1) is a P-selectin ligand.
We have shown that human and murine TIM-1 binds
to P-selectin, and that TIM-1 mediates tethering and
rolling of T helper 1 (Th1) and Th17, but not Th2 and
regulatory T cells on P-selectin. Th1 and Th17 cells
lacking the TIM-1 mucin domain showed reduced
rolling in thrombin-activated mesenteric venules
and inflamed brain microcirculation. Inhibition of
TIM-1 had no effect on naive T cell homing, but it
reduced T cell recruitment in a skin hypersensi-
tivity model and blocked experimental autoimmune
encephalomyelitis. Uniquely, the TIM-1 immunoglob-
ulin variable domain was also required for P-selectin
binding. Our data demonstrate that TIM-1 is a major
P-selectin ligand with a specialized role in T cell traf-
ficking during inflammatory responses and the induc-
tion of autoimmune disease.
INTRODUCTION
The leukocyte adhesion cascade is a central paradigm of inflam-
mation and immunity, involving a multistep process including
tethering, rolling, activation, arrest, crawling, and transmigration
(Butcher, 1991; Springer, 1994; Luster et al., 2005; Ley et al.,
2007). Selectins mediate the first step (tethering and rolling),
allowing circulating leukocytes to sense activating signals on
the endothelium and hence adhere to vessel walls under blood
flow (Ley et al., 2007; Ley and Kansas, 2004; McEver and Zhu,
2010; Zarbock et al., 2011). The inhibition of selectin-dependent
rolling strongly reduces such inflammatory responses, so the
investigation of molecular mechanisms controlling leukocyte542 Immunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc.trafficking, particularly primary adhesion to endothelial cells,
has both biological and clinical relevance (Luster et al., 2005).
The selectin family of cell adhesion molecules has three
members: L-selectin (CD62L), which is constitutively expressed
by most leukocytes, E-selectin (CD62E), which is upregulated
on endothelial cells after cytokine stimulation, and P-selectin
(CD62P), which is stored in endothelial Weibel-Palade bodies
and platelet a-granules and is rapidly expressed by activated
endothelium and platelets and by platelet-derivedmicroparticles
(Ley and Kansas, 2004; McEver and Zhu, 2010). The principal
leukocyte ligand for P-selectin is the mucin P-selectin glycopro-
tein ligand 1 (PSGL-1), which can act as a ligand for all three se-
lectins (Ley and Kansas, 2004; Zarbock et al., 2011). Themajority
of research on selectin ligands has focused onmyeloid cells, and
PSGL-1-independent rolling on P-selectin has been observed
for T cells suggesting that the repertoire of physiological ligands
that interact with endothelial selectins is still incompletely under-
stood (Ley and Kansas, 2004; Zarbock et al., 2011).
The T cell immunoglobulin and mucin domain (TIM) gene
family encodes glycoproteins involved in a variety of immunity-
related processes including T cell proliferation and survival,
tissue inflammation, and atopy (Rodriguez-Manzanet et al.,
2009). In mice, eight TIM genes encode the proteins TIM-1 to
TIM-8, whereas only three TIM genes are found in humans en-
coding TIM-1, TIM-3, and TIM-4 (Rodriguez-Manzanet et al.,
2009). TIM-1 expression has been observed on activated
T cells, B cells, natural killer T (NKT) cells, and dendritic cells
(Rennert, 2011). Several lines of evidence suggest that TIM-1
regulates T cell activity in vivo through responses mediated by
T helper 1 (Th1), Th2, Th17, and regulatory T (Treg) cells (Umetsu
et al., 2005; Meyers et al., 2005; Xiao et al., 2007; Degauque
et al., 2008). TIM-1 is recruited to the T cell receptor signaling
complex and has a costimulatory role (Rodriguez-Manzanet
et al., 2009).
Members of the TIM family share common structural motifs,
such as immunoglobulin variable (IgV)-like and mucin-like
domains on the extracellular portion, a single transmembrane
region, and a cytoplasmic tail that generally contains tyrosine
phosphorylation motifs (Kuchroo et al., 2003). Here we have
Figure 1. TIM-1 Interacts with Selectins
In Vitro Requiring a Specific Glycosylation
Profile and Mediates Tethering and Roll-
ing on Endothelial Selectins under Flow
Conditions
(A and B) Microtiter plates were coated with
5 mg/ml murine or human P-selectin, E-selectin, or
L-selectin, TIM-4 (positive control) (Meyers et al.,
2005) or ICAM-1 (negative control) (Santiago et al.,
2007b) and tested for their ability to bind recom-
binant mouse or human TIM-1, respectively. In
some experiments, 10 mM EDTA was added to
chelate divalent cations. Both murine (A) and hu-
man (B) TIM-1 bound to all three selectins, and
binding was dependent on the presence of diva-
lent cations (*p < 0.0001 compared to ICAM-1
binding).
(C and D) Microtiter plate assays show the binding
of recombinant mouse TIM-1 protein from CHO
(shown in C) and 293T cells (shown in D) to P- and
E-selectin after treatment with a1,(3,4)-fucosi-
dase, tyrosine sulfatase, PNGase, OSGE, and
neuraminidase (*p < 0.001).
(E) Protein A-covered microspheres were coated
with amurine TIM-1 Fc-chimera (Sizing et al., 2007)
or a control mouse IgG Fc-chimera (control beads)
and were infused into glass capillary tubes pre-
coated with P-selectin, E-selectin, or L-selectin,
under physiological shear stress conditions
(2 dyne/cm2) (*p < 0.002, **p < 0.0001). See also
Movies S1 and S2.
(F) The rolling velocity of TIM-1-covered beads
declines as the concentration of P-selectin and
E-selectin increases under physiological flow
conditions. Data represent the means ± SEM of
three independent experiments. In (A), (B), (C), and
(D), data represent means ± SEM of at least three
independent experiments performed in triplicate
for each condition.
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TIM-1 Controls T Cell Traffickingdemonstrated that TIM-1 is a major selectin ligand that mediates
leukocyte rolling on P-selectin in vivo. We also have provided
compelling evidence that TIM-1 controls T cell trafficking during
inflammation and autoimmune disease. Our data have shown
that TIM-1 can be included in the restricted group of major adhe-
sion receptors involved in leukocyte tethering and rolling under
inflammatory conditions (Zarbock et al., 2011).
RESULTS
TIM-1 Binds Selectins In Vitro in a Cell-Free System
The TIM-1 mucin domain is rich in threonine, serine, and proline
residues, providing 56 predictedO-glycosylation sites in humansImmunity 40, 542–5and 32 in mice (Kuchroo et al., 2003). We
hypothesized that TIM-1 might present
carbohydrate moieties to selectins, and
we therefore carried out microtiter plate
binding assays to check for direct binding
between TIM-1 and the three known se-
lectins. We found that both mouse and
human TIM-1 were able to bind all three
selectins in cell-free assays, with higherbinding to P-selectin than E- or L-selectin (Figures 1A and 1B).
The calcium chelator EDTA, completely blocked the binding of
both mouse and human TIM-1 to all three selectins (Figures 1A
and 1B), suggesting that the TIM-1 mucin domain is necessary
for selectin binding. We tested other members of the TIM family
and found that murine TIM-2 and TIM-3 were unable to bind
selectins, suggesting that TIM-1 might be the sole candidate
selectin receptor (see Figure S1 available online).
TIM-1 Requires a1-(3,4)-Fucosylation and Tyrosine
Sulfation for Efficient Binding to P- and E-Selectin
Wenext sought to identify the carbohydratemoieties required for
high-affinity binding between TIM-1 and endothelial selectins. By53, April 17, 2014 ª2014 Elsevier Inc. 543
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TIM-1 Controls T Cell Traffickingtreating recombinant mouse TIM-1 proteins derived from Chi-
nese hamster ovary (CHO) or human embryonic kidney (HEK)
293T cells with different glycosidases, we found that a1-(3,4)-
fucosylation and tyrosine sulfation were the posttranslational
modifications necessary for binding between TIM-1 and selec-
tins (Figures 1C and 1D). The effect of the sulfatase pretreatment
on TIM-1-P-selectin interactions was more pronounced than
on TIM-1-E-selectin. Treatment with Peptide:N-glycosidase
F (PNGaseF) did not inhibit TIM-1 binding, suggesting that
N-linked glycans have no role in the interaction with selectins
(Figures 1C and 1D). Treating TIM-1 with neuraminidase or
O-sialoglycoprotein-endopeptidase did not inhibit TIM-1 binding
either (Figures 1C and 1D), suggesting that sialic acid moieties
are dispensable for the interaction with selectins. These data
suggest that TIM-1 presents a specific glycosylation profile
necessary for selectin binding but that the profile differs from
that of PSGL-1, particularly in the requirement for sialylated car-
bohydrates (Zarbock et al., 2011).
TIM-1 Mediates Capture and Rolling on P-Selectin and
E-Selectin under Flow Conditions In Vitro
The capture and rolling of leukocytes on vascular endothelium
mediated by L-selectin and P-selectin requires shear stress con-
ditions (Zarbock et al., 2011). Therefore we carried out TIM-1-
selectin binding assays under flow conditions in glass capillary
tubes by using 10 mm protein A polystyrene microspheres
covered with a murine TIM-1 Fc-chimera (Sizing et al., 2007).
The TIM-1-covered beads were infused into capillary tubes pre-
coatedwith each of the threemurine selectins under shear stress
conditions of 2 dyne/cm2 (Deban et al., 2010). The TIM-1-
covered microspheres were efficiently captured by P-selectin
(Figure 1E; Movie S1) and E-selectin (Figure 1E; Movie S2) under
these conditions. Notably, TIM-1-mediated tethering and rolling
was more efficient on P-selectin than E-selectin, suggesting that
TIM-1 might preferentially bind P-selectin under flow conditions.
TIM-1 also mediated the transition from capture to rolling inter-
actions, and the rolling velocity was dependent on the quantity
of each selectin used to coat the capillary tubes (Figure 1F).
The rolling of beads on E-selectin was slow (Ley et al., 2007)
and slowed further as the quantity of E-selectin in the coating
increased (Figure 1F). In contrast, TIM-1 did not bind L-selectin
under these flow conditions, suggesting that it might interact
preferentially with selectins expressed on endothelial cells
(Figure 1E). These results demonstrate that TIM-1 can mediate
capture and rolling on P-selectin and E-selectin under flow con-
ditions and might represent an adhesion mechanism that facili-
tates efficient lymphocyte-endothelium interactions in vivo.
The TIM-1 Mucin Domain Is Required for Th1 and Th17
Cell Rolling on P-Selectin In Vitro
To determine the relevance of the TIM mucin domain in selec-
tin binding, we tested the behavior of T cells derived from
Havcr1Dmucin mice, which selectively lack the O-glycosylated
TIM-1 mucin domain encoded by exon 3 of the Havcr1 gene
(Xiao et al., 2012). First, we tested several T cell populations
for TIM-1 expression and found that Th1 and Th17 cells ex-
pressed the highest amount of TIM-1 on the cell membrane
and intracellularly, compared to naive CD4+ T cells and Treg
cells, whereas TIM-1 was preferentially expressed intracellularly544 Immunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc.in Th2 cells (Figures S2A and S2B). Notably, TIM-1 was ex-
pressed at higher amounts on the surface of Th1 cells, just
beneath the plasma membrane and partially in endosomal
pools, but TIM-1 mRNA amount was lower in Th1 cells than in
naive T cells, in which TIM-1was exclusively intracellular (Figures
S2C–S2G). Also, as previously described (Xiao et al., 2012), we
found no differences in the expression of TIM-1 between wild-
type (WT) and Havcr1Dmucin T cells (data not shown).
We carried out further in vitro assays in capillary tubes pre-
coated with recombinant P-selectin or E-selectin and found
that Havcr1Dmucin T cells activated with concanavalin A (ConA
blasts) were consistently deficient in their ability to tether and
roll on P-selectin under flow conditions (Figure 2A), providing
more evidence that the TIM-1 mucin domain is necessary for
interactions with P-selectin. Furthermore, Th1 and Th17 cells
lacking the mucin domain also showed a significant reduction
in P-selectin-mediated tethering and rolling (Figures 2A and
2B; Movies S3 and S4), suggesting that despite the presence
of PSGL-1 on these cells, TIM-1 is nevertheless required for
effective P-selectin-dependent tethering and rolling. Impor-
tantly, activated Th1 and Th17 cells from WT and Havcr1Dmucin
mice expressed comparable amounts of several adhesion mole-
cules and activation markers (Figure S3), suggesting there were
no potential adhesion defects associated with the Havcr1Dmucin
mutation.
Although the loss of PSGL-1 impaired not only Th1, but also
Th2 and Treg cell rolling on P-selectin (Figures S4A, S4E, and
S4F), both Havcr1Dmucin Th2 and Treg cell subsets displayed
no defects in their rolling ability on P-selectin (Figures 2A and
2C), suggesting that TIM-1-P-selectin adhesive interactions are
a prerogative of Th1 and Th17 cells. Also Havcr1Dmucin bone-
marrow-derived polymorphonuclear neutrophils (PMNs), which
do not express TIM-1, displayed normal rolling activity (Fig-
ure 2A), suggesting that the adhesion defect in Havcr1Dmucin
mice is specific to T cells. No differences in rolling velocity
were observed betweenWT andHavcr1Dmucin T cells (Figure 2C),
suggesting that TIM-1 does not influence the quality of rolling
interactions when functional PSGL-1 is highly expressed.
Because TIM-1 also mediated rolling on E-selectin in vitro, we
investigatedwhether the TIM-1mucin domain is also required for
E-selectin-dependent rolling. In contrast to the P-selectin exper-
iments, we found thatHavcr1Dmucin ConA blasts, Th1, Th17, Th2,
and Treg cells showed no defects in their interactions with
E-selectin in vitro under flow conditions when compared to WT
cells (Figure 2D). There was also no change in rolling velocity
when Havcr1Dmucin cells were tested on E-selectin (Figure 2E),
suggesting that the TIM-1 mucin domain plays a specific role
in P-selectin-dependent rolling.
TIM-1 Mediates Th1 and Th17 Cell Capture and Rolling
In Vivo
To establish the in vivo relevance of TIM-1 in leukocyte adhesion
interactions, we carried out intravital microscopy experiments
in exposed mesenteric venules pretreated with thrombin, which
rapidly induces the expression of endothelial P-selectin (Deban
et al., 2010), focusing on proinflammatory Th1 and Th17 cells
that displayed defective P-selectin-dependent rolling in vitro
(Figure 2A). Th1 and Th17 cells from Havcr1Dmucin mice showed
a significant reduction in the ability to roll on P-selectin
Figure 2. The TIM-1 Mucin Domain Is Required for the Capture and Rolling of Th1 and Th17 Cells on P-Selectin under Physiological Flow
Conditions In Vitro
(A–E) Treg cells or CD4+ T cells stimulated with concanavalin A (ConA) or polarized toward Th1, Th17, or Th2 phenotypes were infused into capillary tubes
precoated with 5 mg/ml P-selectin or E-selectin under shear stress conditions (2 dyne/cm2) (*p < 0.002; **p < 0.0003; ***p < 0.0001). Bone-marrow-derived PMNs,
which do not express TIM-1, were used as negative controls. (B) Representative images of WT and Havcr1Dmucin Th1 cells rolling on P-selectin, showing a
consistently lower number of rolling Havcr1Dmucin Th1 cells. See also Movies S3 and S4. (C and E) Rolling velocities of WT and Havcr1Dmucin ConA blasts, Th1,
Th17, Th2, and Treg cells on P- and E-selectin. Data represent means ± SEM of four independent experiments. For rolling velocities, data represent means ± SEM
of at least 100 cells per condition.
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TIM-1 Controls T Cell Traffickingcompared to WT cells (Figures 3A and 3B; Movie S5). Impor-
tantly, the number of total tethers was also reduced for Th1
and Th17 cells (Figure 3C), suggesting that TIM-1 can also
mediate T cell tethering in vivo. As expected, Havcr1Dmucin
PMNs displayed no defects in their ability to interact with P-
selectin in vivo (Figures 3A and 3C), indicating that the defect
in rolling is lymphocyte-specific. As shown in vitro, we found
no differences in rolling velocities between WT and Havcr1Dmucin
cells, suggesting that TIM-1 does not influence the quality of
activated T cell rolling on P-selectin in vivo (Figures 3D and 3E).
The TIM-1 IgV Domain Is Also Required for T Cell Rolling
on P-Selectin
Wenext investigated the potential role of the TIM-1 IgV domain in
P-selectin binding by testing cells in the presence of two anti-
bodies that specifically block this domain: RMT1-10 and 4A2.2
(Xiao et al., 2007; Sizing et al., 2007). We carried out intravital
microscopy experiments in exposed mesenteric venules pre-
treated with thrombin. We found that inhibiting the IgV domain
with antibodies led to a significant reduction in the ability of the
cells to roll on P-selectin in vivo, compared to cells treated
with a control IgG antibody, suggesting that the TIM-1 IgV
domain is required for interactions with P-selectin (Figure 4A).
In addition, the total number of tethers was significantly reduced
when the IgV domainwas blocked, suggesting that the TIM-1 IgV
domain is required for tether formation under flow conditions(Figure 4B). As shown for the mucin domain, there was no differ-
ence in rolling velocity between cells treated with anti-IgV anti-
bodies and the control antibody (Figures 4C and 4D), providing
further evidence that TIM-1 does not affect the quality of rolling
interactions in the presence of functional PSGL-1. The IgV
domain has not previously been shown to play a role in tethering
or rolling on other selectin ligands and our results suggest that
TIM-1 therefore uses a regulatory mechanism that is unique
within the family of selectin receptors.
To investigate the role of the TIM-1 mucin and IgV domains
in more detail, we carried out in vitro binding assays between
P-selectin and truncated TIM-1 proteins. We found that
removing the mucin or IgV domain almost completely inhibited
the binding between TIM-1 and P-selectin (Figure 4E). Further-
more, treatment of Havcr1Dmucin Th1 cells with the TIM-1 IgV
domain-blocking antibodies RMT1-10 or 4A2.2 did not reduce
their in vivo ability to roll and tether on P-selectin any further
in thrombin-treated mesenteric venules (Figure 4F; data not
shown). Taken together, these data demonstrate that the IgV
and mucin domains of TIM-1 are both pivotal for the adhesive
interaction between TIM-1 and P-selectin.
TIM-1 Mediates T Cell Recruitment in Inflamed Skin
We next evaluated the potential pathophysiological role of the
interaction between TIM-1 and P-selectin in leukocyte trafficking
in vivo during inflammation, by using a contact hypersensitivityImmunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc. 545
Figure 3. TIM-1 Mediates Tethering and Rolling of Th1 and Th17 Cells In Vivo
Th1 and Th17 cells were generated frommurineWTandHavcr1Dmucin CD4+ cells. Bonemarrow-derivedPMNswere used as negative controls. Cells were injected
intravenously in mice in which the exposed mesenteric vessels were pretreated with bovine thrombin to upregulate P-selectin on the vascular endothelium.
(A) Havcr1Dmucin T cells have a significantly reduced ability to roll on P-selectin in vivo (*p < 0.002 compared to WT cells). See also Movie S5.
(B) Representative images of Th1 cells rolling in mesenteric vessels. Cells are the white spots inside the venules (arrow tips). Scale bar represents 100 mm.
(C) The number of tethers (each new interactionwith the vessel wall) is shown (*p < 0.03 and **p < 0.004 compared to the correspondingwild-type cells). Data in (A)
and (C) represent means ± SEM of 13–15 independent experiments for a total of 15–20 total venules per condition.
(D and E) Havcr1Dmucin Th1 (D) and Th17 (E) cells display no defects in their rolling velocity in mesenteric venules, compared to WT cells. Rolling velocities
represent the mean ± SEM of at least 100 cells per condition (left panel). The distribution of leukocyte rolling velocities is also shown (right panel).
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TIM-1 Controls T Cell Traffickingmodel (CHS) in which P-selectin on the skin endothelium is
necessary for activated T cell recruitment (Austrup et al.,
1997). To evaluate the ability of WT and Havcr1Dmucin Th1 cells
to migrate in the inflamed ear pinnae, we sensitized WT mice
with 1-fluoro-2,4-dinitrobenzene (DNFB) and challenged
5 days later on the right ear. After 24 hr, Th1 cells were labeled
with CFSE dye and injected into the CHS mice. We found that
Havcr1Dmucin Th1 cells showed a 48% reduction in their ability
to migrate in the inflamed skin compared to WT cells (Figure 5A),
suggesting that TIM-1 plays a role in activated T cell migration in
the inflamed skin. In addition, the Havcr1Dmucin Th1 cells failed to
amplify the inflammatory response in the challenged ear by
increasing ear thickness compared to WT Th1 cells (Figure 5B),546 Immunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc.clearly supporting a pathological role for TIM-1-dependent T cell
trafficking.
TIM-1 Controls Activated T Cell Interactions with
Inflamed Pial Vessels
We investigated the impact of interactions between TIM-1 and
P-selectin during inflammatory responses in more detail by
studying the role of TIM-1 in T cell adhesion within the inflamed
venules of the central nervous system (CNS). We carried out
intravital microscopy experiments in the inflamed brain pial
vessels, a key point for T cell ingress into the CNS during
experimental autoimmune encephalomyelitis (EAE). We there-
fore used an experimental model of LPS-induced vasculitis
Figure 4. The TIM-1 IgV Domain Is Required for P-Selectin-Dependent Rolling In Vivo
(A–D) WT Th1 cells were treated with control rat IgG or the blocking anti-TIM-1 antibodies RMT1-10 or 4A2.2, which recognize epitopes in the TIM-1 IgV domain
(Xiao et al., 2007; Sizing et al., 2007). (A) Cells treated with RMT1-10 and 4A2.2 showed a strongly reduced ability to roll on P-selectin (*p < 0.005 and **p < 0.04
compared to cells treatedwith rat IgG). (B) RMT1-10 and 4A2.2 treatments also reduced the number of total tethers (*p < 0.008 and **p < 0.03 compared to control
cells). Data in (A) and (B) represent means ± SEM of 3–4 independent experiments for a total of 6–8 total venules per condition. (C and D) Cells treated with both
RMT1-10 (C) and 4A2.2 (D) showed no defects in their rolling velocity in mesenteric venules. Rolling velocities represent the mean ± SEM of at least 50 cells per
condition. The distribution of leukocyte rolling velocities is also shown (right panels).
(E) Microtiter plate assays showing the binding of full-length versus truncated TIM-1 proteins to P-selectin (*p < 0.001 compared to entire TIM-1 protein). ICAM-1
was used a negative control for TIM-1 binding.
(F) Effect of RMT1-10 antibody on Havcr1Dmucin Th1 cell tethering and rolling in thrombin-treated mesenteric venules. Data represent means ± SEM of two
experiments for a total of 5–6 venules per condition.
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TIM-1 Controls T Cell Traffickingmimicking early CNS vascular inflammation during EAE, in
which the inhibition of P-selectin almost completely abolishes
T cell rolling (Piccio et al., 2002). Our results showed that the
Havcr1Dmucin mutation caused a significant reduction in the abil-
ity of Th1 and Th17 cells to roll, and their capacity tomaintain firm
adhesion in the inflamed brain pial venules, compared to WT
cells (Figures 6A and 6B). Thus, as shown in mesenteric venules,
TIM-1 is also necessary to control adhesion interactions in the
inflamed brain microcirculation.
TIM-1 Controls T Cell Accumulation in the Inflamed CNS
and the Induction of Autoimmune Disease
The pathological role of TIM-1 in T cell trafficking was investi-
gated by studying the ability of TIM-1 to control T cell recruitment
in the CNS during EAE. We therefore generated in vitro
MOG35–55-specific Th1 cells from WT and Havcr1
Dmucin mice
(Lees et al., 2008) and evaluated their migration in the CNS by us-
ing amodel of EAE (Kerfoot et al., 2004).We found no differences
in interferon-g (IFN-g) production and adhesion molecule
expression between WT and Havcr1Dmucin MOG35–55-specific
Th1 cells (Figure S5). However, Havcr1Dmucin Th1 cells showed
a significant reduction in the ability to migrate compared to WT
cells (Figure 6C), suggesting that TIM-1 plays a role in activated
T cell migration in the inflamed CNS. Notably, we also found that
MOG35–55-specific Th1 cells obtained from Havcr1
Dmucin miceinduced a significantly less severe form of EAE compared
to WT cells (Figure 6D). This clearly demonstrates that TIM-1
expression plays a pivotal role in the trafficking of T cells into
the CNS and consequently in the induction of EAE.
We also investigated the induction of EAE in C57BL/6JWT and
Havcr1Dmucin mice by immunization with the MOG35–55 peptide.
The disease was significantly less severe in the Havcr1Dmucin
mice (Figure 6E), with reduced demyelination and inflammatory
cell infiltration in the CNS parenchyma (Figure 6F), indicating a
key role for TIM-1 in EAE pathogenesis. Notably, CD4+ T cells
isolated from draining lymph nodes of the WT and Havcr1Dmucin
EAE mice 7 days after immunization had a similar capacity to
proliferate (Figure 6G), suggesting that the inhibition of EAE in
Havcr1Dmucin mice reflects a defect in T cell trafficking, rather
than antigen-dependent T cell activation.
TIM-1 and PSGL-1 Cooperate to Mediate Tethering and
Rolling In Vitro and In Vivo
PSGL-1 is currently regarded as the major P-selectin ligand ex-
pressed on activated T cells (Ley and Kansas, 2004; Zarbock
et al., 2011). Selplg/ Th1 cells showed a reduced ability to
interact with endothelial selectins under flow conditions
in vitro, but residual interactions with P-selectin still occur in
PSGL-1-deficient T cells in vitro and in vivo (Figure S4).We there-
fore investigated whether the residual rolling observed inImmunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc. 547
Figure 5. TIM-1 Mediates T Cell Recruitment in the Inflamed Skin
Mice were sensitized with DNFB to induce cutaneous hypersensitivity (CHS)
andwere challenged again 5 days later on each side of the right ear pinnaewith
DNFB. The ear thickness was measured 0, 24, and 48 hr after challenge.
(A) 10 3 106 CFSE-labeled Th1 cells from WT and Havcr1Dmucin mice were
transferred to CHS mice 24 hr after the ear pinnae were painted, and Th1
accumulation was evaluated 24 hr later by flow cytometry (*p < 0.02).
(B) The injection of WT but not Havcr1Dmucin Th1 cells increased the inflam-
matory response in the challenged ear (*p < 0.01). In both (A) and (B), results
represent the mean ± SEM of 9–11 mice per condition.
Immunity
TIM-1 Controls T Cell TraffickingSelplg/ cells is mediated by TIM-1-dependent interactions.
We generated Selplg/ Havcr1Dmucin mice and found that the
absence of the TIM-1 mucin domain in Selplg/ Havcr1Dmucin
Th1 cells inhibited PSGL-1-independent residual rolling in capil-
lary tubes coated with P-selectin, whereas rolling on E-selectin
was not affected (Figure 7A).
As shown for Havcr1Dmucin cells (Figure 3), Selplg/ Th1
cells also displayed a reduced ability to roll in thrombin-
treated mesenteric venules, demonstrating that TIM-1 and
PSGL-1 cooperate to mediate primary adhesion (Figure S4C)
(D’Ambrosio et al., 2004). In agreement with our in vitro data,
we found that Selplg/ Havcr1Dmucin Th1 cells showed a signif-
icant reduction in their ability to tether and roll on P-selectin
compared to Selplg/ cells also in mesenteric venules (Fig-
ure 7C), and comparable inhibition was also observed by block-
ing PSGL-1 on Havcr1Dmucin Th1 cells with antibody 4RA10
(Figure 7C), suggesting that TIM-1mediates a significant propor-
tion of the residual tethering and rolling interactions observed in
Selplg/ cells. Accordingly, the TIM-1 IgVdomain-blocking anti-
body RMT1-10 significantly inhibited both residual tethering and
rolling interactions in Selplg/ cells (Figure 7E). As expected, no
differences in rolling velocities were observed betweenSelplg/
and Selplg/ Havcr1Dmucin double mutant Th1 cells in vitro and
in vivo (Figures 7B and 7D). Furthermore, intravital microscopy548 Immunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc.in the inflamed brain microcirculation showed similar results to
those described in the mesenteric venules, further supporting
the hypothesis thatPSGL-1 andTIM-1concur to achieve efficient
rolling interactions during inflammation and that TIM-1 is involved
in PSGL-1-independent residual rolling (Figure 7F).
TIM-1 and PSGL-1 Cooperate to Control Activated But
Not Naive T Cell Trafficking
To evaluate the concurrency of TIM-1 and PSGL-1 in T cell
trafficking under inflammatory conditions in more detail, we
analyzed the accumulation of Havcr1Dmucin, Selplg/, and
Selplg/ Havcr1Dmucin Th1 cells in the CHS and inflamed
CNS. As expected, the lack of either PSGL-1 or TIM-1 cells in
the CHS model led to a significant inhibition of T cell accumula-
tion, with PSGL-1 deficiency having a greater impact, probably
due to the additional role of PSGL-1 as a rolling receptor for
E-selectin in this model (Figure 7G) (Austrup et al., 1997). There
was no further reduction in accumulation when we used dou-
ble-mutant Selplg/ Havcr1Dmucin T cells in the CHS experi-
ments, potentially reflecting the very strong inhibition due to
the PSGL-1 deficiency in this model. When we studied nonanti-
gen-specific Th1 cell accumulation in the inflamed CNS in an
animal model with relevance to EAE in which cerebral vessels
express P-selectin (Kerfoot et al., 2004), there was a significantly
higher decrease in the accumulation of Havcr1Dmucin T cells
compared to Selplg/ T cells (Figure 7H). These data suggest
that TIM-1 better compensates PSGL-1 deficiency by playing a
more prevalent role in Th1 cell accumulation in the inflamed
brain. There was no additional reduction in T cell accumulation
when we used double-mutant Selplg/ Havcr1Dmucin Th1 cells
compared to Havcr1Dmucin Th1 cells, further supporting a preva-
lent role for TIM-1 in the accumulation of T cells in the CNS.
Taken together, these results suggest that TIM-1 and PSGL-1
cooperate to mediate activated T cell trafficking during inflam-
matory diseases, with TIM-1 playing the more important role in
activated T cell trafficking in the CNS and PSGL-1 having the
more prevalent role in the inflamed skin.
Finally, we compared the roles of PSGL-1 and TIM-1 in the
homing of naive T cells by using intravital microscopy in high
endothelial venules (HEVs) of Peyer’s patches and T cell accu-
mulation assays in secondary lymphoid organs in naive recipient
mice.We found that naive CD4+ T cells lacking PSGL-1were less
capable of firm adhesion in HEVs and accumulation in Peyer’s
patches and lymph nodes (Figures 7I and 7J), presumably
because they were less able to bind chemokines exposed on
the surface of HEVs (Zarbock et al., 2011). Notably,Havcr1Dmucin
naive T cells had no defects in their rolling and arrest in HEVs or
accumulation in lymphoid organs, compared to WT cells (Fig-
ure 7I and 7J), suggesting that TIM-1 has a more specialized
role in activated T cell recruitment to sites of inflammation.
Thus, TIM-1 is a major P-selectin ligand and a key trafficking
mechanism for Th1 and Th17 cells during inflammatory and
autoimmune diseases.
DISCUSSION
In this study, we have provided direct evidence that TIM-1 is a
ligand for endothelial selectins and that it controls the tethering
and rolling of activated T cells in the inflamed microcirculation
Figure 6. TIM-1 Controls T Cell Trafficking in the Inflamed CNS and the Induction of EAE
(A) WT and Havcr1Dmucin Th1 and Th17 cells ability to roll and adhere firmly in LPS-inflamed brain pial vessels, in intravital microscopy experiments (**p < 0.008;
*p < 0.01; ***p < 0.007). Data are mean ± SEM of three experiments for a total of 8–9 venules per condition.
(B) Representative images of brain venules showing adhered Th1 cells as white spots inside the vessels (arrow tips). Scale bar represents 100 mm.
(C) 53 106 MOG35–55-specific Th1 cells were labeled with CFSE and injected into C57BL/6JWTmice treated 5 hr previously with 20 ng pertussis toxin (PTX). The
accumulation of CSFE+ cells in the CNS was evaluated 60 hr after cell transfer. Data represent means ± SEM of 12 mice per condition from two experiments
(*p < 0.006).
(D) 53 106 MOG35–55-specific Th1 cells were transferred in C57BL/6J WTmice. Data represent the mean ± SEM of ten mice per condition from two experiments
(*p < 0.05).
(E) EAE was actively induced by immunization with the MOG35–55 peptide. Data represent the mean ± SEM of ten mice per condition from two independent
experiments with similar results (*p < 0.05).
(F) Hematoxylin and eosin and Spielmeyer stainings are shown at disease peak.
(G) CD4+ T cells were isolated from the draining lymph nodes 7 days after immunization with theMOG35–55 peptide and the proliferative responsewas determined.
Data are shown as counts per minute (CPM) of [3H]-thymidine radioactivity, and represent the mean ± SD of five mice per condition.
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demonstrated that TIM-1 is a major P-selectin ligand, and our
results fulfill all criteria for the definitive assignment of TIM-1 as
a selectin ligand, namely: (1) microspheres covered with TIM-1
can roll on selectins under flow conditions, (2) monoclonal anti-
bodies against TIM-1 block selectin-dependent T cell rolling
in vitro and in vivo, and (3) the mutation of the Havcr1 gene im-
pairs selectin-mediated T cell functions on intact cells in vitro
and in experimental models in vivo (Zarbock et al., 2011).
The existence of P-selectin ligands other than PSGL-1 on
T cells (and their ability to mediate rolling interactions) has
been predicted, but the identity and precise role of these ligandsin leukocyte trafficking has been unclear (Ley and Kansas, 2004).
Although PSGL-1 has been shown to mediate the rolling of neu-
trophils, monocytes, and T cells, our data show that TIM-1 plays
a more specialized role in the trafficking of T cells. Furthermore,
whereas PSGL-1 is involved in naive T cell homing to lymphoid
organs and leukocyte trafficking during inflammation, TIM-1
has amore specialized role in activated T cell recruitment to sites
of inflammation, suggesting a level of diversity between PSGL-1
and TIM-1.
The significant reduction in the ability of Havcr1Dmucin Th1 and
Th17 cells to roll on P-selectin was observed in the presence of
high amounts of functional PSGL-1 on their surface. Indeed, ourImmunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc. 549
Figure 7. TIM-1 and PSGL-1 Concur to Control Activated T Cell Rolling on P-Selectin and T Cell Trafficking in Inflamed Tissues
(A) Th1 cells were infused into capillary tubes precoated with P-selectin or E-selectin (*p < 0.00001; **p < 0.0003) Data represent the mean ± SEM of four
experiments.
(B) Rolling velocities in capillary tubes coated with P-selectin or E-selectin are shown (*p < 0.001 and **p < 0.008 compared to WT cells). Rolling velocities
represent the mean ± SEM of at least 50 cells per condition.
(C) Shown is the ability to tether and roll in thrombin-treatedmesenteric venules. Data obtained by treatingHavcr1Dmucin cells with antibody 4RA10 are also shown
(*p < 0.001 and **p < 0.02 compared to WT cells). Data represent the mean ± SEM of 10 independent experiments for a total of 16–17 venules per condition.
(D) Rolling velocities are shown in mesenteric venules. Rolling velocities represent the mean ± SEM of at least 50 cells per condition. The distribution of leukocyte
rolling velocities is also shown in vivo (right panel).
(E) Selplg/ Th1 cells treated with RMT1-10 showed a reduced ability to tether ad roll on P-selectin in vivo, compared to cells treated with the control rat IgG
(*p < 0.05, left panel; *p < 0.002, right panel). Data represent the mean ± SEM of three experiments for a total of seven venules per condition.
(legend continued on next page)
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TIM-1 Controls T Cell Traffickingstudies showed that the inhibition of TIM-1 in Th1 and Th17 cells
strongly reduced rolling on P-selectin in vitro and in vivo, and
PSGL-1-independent residual rolling was inhibited by TIM-1
inactivation, clearly indicating that TIM-1 is a major P-selectin
ligand on T cells. Our data show that both TIM-1-P-selectin
and PSGL-1-P-selectin proadhesive mechanisms are necessary
to achieve ‘‘fully efficient’’ recruitment and reveal that the TIM-1-
P-selectin molecular pathway is concurrently involved in T cell
trafficking at the regulatory level of cell tethering and rolling
(D’Ambrosio et al., 2004). Notably, TIM-1 does not appear to
affect Th2 and Treg cell rolling, suggesting that TIM-1 differen-
tially regulates Th1 and Th17 versus Th2 and Treg cell trafficking,
playing a restricted role in the control of Th1 and Th17 cell
trafficking.
TIM-1 requires posttranslational fucosylation and tyrosine
sulfation for efficient binding to both P- and E-selectin, whereas
PSGL-1 does not require tyrosine sulfation for binding to
E-selectin (Zarbock et al., 2011). Moreover, TIM-1-selectin bind-
ing does not require sialylated glycans, which are instead critical
for the binding of other receptors such as PSGL-1 and CD44
suggesting that TIM-1 presents a specific glycosylation profile
necessary for selectin binding, with clear differences to PSGL-1
andother ligands, particularly in the requirement of sialylatedcar-
bohydrates (Zarbock et al., 2011). Inhibiting the mucin domain of
TIM-1 in activated T cells causes rolling defects on P-selectin but
notE-selectin, suggesting that the interactionbetweenTIM-1and
P-selectin has a more significant role in T cell trafficking and/or
that E-selectin-dependent rolling mediated by TIM-1 could be
masked by the functional redundancy of other selectin ligands.
We also sought to determine the role of individual TIM-1 do-
mains in selectin binding. We showed that the mucin domain is
not required for T cell activation in the presence of an antigen,
but it is selectively involved in the interaction with P-selectin
in vitro and in vivo. Our results revealed that IgV domain-blocking
antibodies also inhibit rolling on P-selectin in vivo and that both
the mucin and IgV domains are necessary for TIM-1-selectin
binding. Notably, the IgV domain has not previously been shown
to be required for selectin binding. The IgV domain of TIM
proteins was shown to share functional characteristics with
Ca2+-dependent (C-type) lectins and SIGLEC sialic acid-binding
proteins, which also play a role in leukocyte trafficking (Wilker
et al., 2007). We hypothesize that the IgV domain might be
engaged via an intramolecular association with the TIM mucin
domain, which might open up under shear conditions.
In addition to its presence on the cell surface, TIM-1 was pre-
viously found in large intracellular pools in endosomes, the Golgi
apparatus, and lysosomal compartments (Santiago et al., 2007a;
Balasubramanian et al., 2012; Santiago et al., 2007b). In naive,
Th2, and Treg cells, we found substantial intracellular pools of
endogenous TIM-1 but very lowTIM-1 expression on the surface.(F) Rolling and arrest interactions are shown in intravital microscopy experiment
(G and H) Accumulation of WT, Havcr1Dmucin, Selplg/, and Selplg/ Havcr1D
pertussis toxin-treated mice (H) (*p < 0.01, **p < 0.001 and ***p < 0.03). Data re
experiment from a series of two with similar results.
(I) Rolling and arrest of naive CD4+ T cells in Peyer’s patches HEVs (*p < 0.03 c
condition for a total of nine venules per condition.
(J) Accumulation of exogenous naive CD4+ T cells in lymphoid organs of WT resti
Data represent the mean ± SEM of six mice per condition from one representatiIn contrast, TIM-1 expression was upregulated on the surface of
Th1andTh17cells, butwas foundpredominantly just beneath the
plasmamembrane. These results suggest that TIM-1 is poised to
be exposed on the cell surface after activation under specific
conditions and that TIM-1 plays a role in lymphocyte extravasa-
tion as an activation-dependent primary adhesion molecule.
Moreover, recent data suggest that cells transfected with TIM-1
expose the mucin domain on the cell surface following intracel-
lular calcium release (Santiago et al., 2007b), and a ‘‘flip-flop’’
model was proposed in which the TIM-1 extracellular domain re-
sides on the cytosolic side of themembrane, with the IgV domain
interactingwith phosphatidylserine (Santiago et al., 2007a). How-
ever, TIM-1 molecule in Th2 and Treg cells might also not be
properly glycosylated, compared to Th1 and Th17 cells, and its
differential role as P-selectin rolling receptor might reflect both
distribution andglycosylationdifferencesbetweenTcell subsets.
Our findings show that TIM-1 mediates T cell trafficking in
three models of inflammatory conditions: thrombin-activated
mesenteric vessels, the inflamed brain endothelium, and CHS
in the skin. Moreover, we showed that TIM-1 plays a prevalent
role in Th1 cell accumulation in the CNS when compared to in-
flamed skin, suggesting that TIM-1 is important to achieve tissue
specificity in leukocyte trafficking. We also show that TIM-1 is
required for the recruitment of Th1 and Th17 cells, which are
potent inducers of inflammation and autoimmunity, suggesting
that interference with TIM-1 activity might provide a therapeutic
approach in T cell-mediated diseases. Considering that Th1 and
Th17 cells facilitate pathogen clearance and promote antitumor
immunity, we hypothesize that the TIM-1-P-selectin interaction
might also play a role during infection and cancer (Ruffell et al.,
2010; Zhu et al., 2010).
In conclusion, our findings collectively indicate that TIM-1 is a
major P-selectin ligand and a pivotal trafficking mechanism for
Th1 and Th17 cells during inflammation. Our results refine the
paradigm of the leukocyte adhesion cascade and show that
the primary adhesion of T cells to P-selectin in vivo is no longer
exclusively dependent on PSGL-1, but also requires TIM-1,
thereby providing a form of concurrency in leukocyte trafficking
between these two critical components of the immune system.
EXPERIMENTAL PROCEDURES
Mice
Selplg/ mice and C57BL/6J age-matched controls were obtained
from Jackson Laboratories. Havcr1Dmucin mice were obtained as previously
described (Xiao et al., 2012). All mice were housed and used according to
the current European Community rules.
Antibodies and Fluorescence-Activated Cell Sorting (FACS) Analysis
The following rat-anti mouse monoclonal antibodies were used: anti-PSGL-1
(clone 4RA10; BD Bioscience), PE-conjugated anti-CD25 (eBioscience),s in LPS-treated cerebral vessels (*p < 0.001; **p < 0.04).
mucin Th1 cells in the inflamed ear pinnae of CHS mice (G) and in the CNS of
present the means ± SEM of five mice per condition from one representative
ompared to WT cell arrest). Data represent the mean ± SEM of four mice per
ng mice at 2 hr after transfer (*p < 0.003 and **p < 0.04 compared to WT cells).
ve experiment from a series of three with similar results.
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TIM-1 Controls T Cell Traffickingpurified anti-a4 integrin (clone PS-2), anti-LFA-1 (clone TIB-213), anti-L-selec-
tin (clone Mel-14), anti-CD44 (clone MJ64) rat anti mouse TIM-1 RMT1-10,
4A2.2, and 5F12 clones (Xiao et al., 2007; Sizing et al., 2007; Xiao et al.,
2012). Samples were collected with theMACSQuant Analyzer (Miltenyi Biotec)
and analyzed with the FlowJo software (Tree Star). Intracellular cytokines were
evaluated as described in the Supplemental Information.
Real-Time PCR for TIM-1 Expression
These procedures are described in the Supplemental Information.
Microtiter Plate Binding Assay
The assay was carried out as previously described (Deban et al., 2010). A brief
description including treatment with glycosidases is provided in the Supple-
mental Information.
Under Flow Assays in Capillary Tubes
Microcapglasscapillary tubes (100ml; Sigma-Aldrich)were coatedwithdifferent
concentrations of mouse P-selectin or E-selectin Fc-chimeras. Mean site den-
sity of selectins in our experiments were 1,560 ± 74 molecules/mm2 for 5 mg/ml
selectin, 2,130 ± 145 molecules/mm2 for 10 mg/ml selectin, 2,770 ± 150 mole-
cules/mm2 for 20 mg/ml selectin and 3,321 ± 94 molecules/mm2 for 30 mg/ml
selectin (see Supplemental Information for more details).
For the experiments with TIM-1-covered microspheres, 9.7 mm protein
A-covered nondeformable polystyrene microspheres (Bangs Laboratories)
were washed and incubated for 45 min at room temperature with 10 mg/ml
mouse PSGL-1 Fc chimera (R&D Systems) or 10 mg/ml murine TIM-1 Fc-
chimera (Sizing et al., 2007), following the manufacturer’s instructions. Mean
site density on TIM-1-coated microspheres was 2410 sites/mm2. Beads
covered with mouse IgG Fc-chimera (R&D Systems) were used as a negative
control. In separate experiments, T cell populations were fluxed into the tubes
at a density of 106 cells/ml. T cells or beads were fluxed at a shear stress of 2
dyne/cm2 in a buffer containing 1mMCa2+ andMg2+, 10% vol/vol FBS in PBS.
Adhesion interactions were recorded and analyzed as previously described
(Deban et al., 2010).
CD4+ T Cell Isolation and Th1, Th17, Th2, and Treg Cell Production
These procedures are described in the Supplemental Information.
Generation of MOG35–55-Specific Th1 Cells
MOG35–55-specific Th1 cells were generated as previously described (Lees
et al., 2008). A brief description is provided in the Supplemental Information.
PMN Isolation from Mouse Bone Marrow
Immaturemouse bone-marrow PMNswere isolated from the femurs and tibias
of WT and Havcr1Dmucin mice as previously described (Deban et al., 2010).
Intravital Microscopy in Mesenteric Vessels
Intravital microscopy experiments were carried out as previously described
(Deban et al., 2010). A brief description is provided in the Supplemental
Information.
Intravital Microscopy in Peyer’s Patches Microvasculature and
Naive T Cell Accumulation Assays in Secondary Lymphoid Organs
These procedures are described in the Supplemental Information.
Cutaneous Hypersensitivity
Mice were sensitized by applying to the shaved abdomen 30 ml of acetone/
olive oil (4:1; Sigma-Aldrich) plus 0.5% (v/v) 1-fluoro-2,4-dinitrobenzene
(DNFB; Sigma-Aldrich). Five days later, sensitized mice were challenged
with 7 ml of acetone/olive oil (4:1) plus 0.3% DNFB on each side of the right
ear pinnae. For the control condition the left ear was painted with an identical
amount of vehicle. The ear thicknesswasmeasured at times 0 and 24 and 48 hr
after challenge with a dial thickness gauge (Swiss Precision Instruments). In
Th1 transfer experiments, 103 106 Th1 cells labeled with green carboxyfluor-
escein succinimidyl ester (CFSE; Invitrogen) were injected intravenously 24 hr
after ear pinnae painting, and 24 hr later, ears were processed as previously
described to isolate migrated leukocytes (DeKrey and Titus, 1999).552 Immunity 40, 542–553, April 17, 2014 ª2014 Elsevier Inc.Intravital Microscopy in Brain Vessels
Intravital microscopy experiments were carried out in inflamed brain microcir-
culation in an experimental model mimicking early inflammation during EAE
were performed as previously described (Piccio et al., 2002). A brief descrip-
tion is provided in the Supplemental Information.
Active and Transfer EAE Induction
For active EAE induction, 6- to 8-week-old C57Bl/6J WT and Havcr1Dmucin
mice were immunized subcutaneously in the flanks and at tail base with
150 mg of MOG35–55 peptide in 200 ml emulsion consisting of equal
volumes of PBS and CFA supplemented with 0.8 mg/mouse Mycobacterium
tuberculosis (strain H37Ra; Becton Dickinson). Mice received 20 ng of
pertussis toxin (PTX; List Biological Laboratories) intravenously at the time of
immunization and 48 hr later. For passive-transfer EAE induction, C57Bl/6J
WT mice were injected with 20 ng PTX 4 days and 1 day before cell transfer.
The day after the second PTX injection, 5 3 106 WT or Havcr1Dmucin
MOG35–55-specific Th1 cells were injected intravenously. The EAE clinical
course was recorded daily as previously described (Piccio et al., 2002).
Proliferation Assays from EAE Mice
CD4+T cells were isolated fromWTandHavcr1Dmucin EAEmice 7 days after im-
munization with MOG35–55 peptide. Cells were restimulated in vitro in the pres-
enceof antigenandpulsed for 18hrwith 1mCi/well of [3H]-thymidine.Cellswere
then collected and radioactivity was detected with a b-counter (Perkin-Elmer).
Neuropathology
Mice were sacrificed at the disease peak, the spinal cords were collected and
frozen, and 10 mm sections were analyzed with hematoxylin and eosin staining
for the detection of inflammatory infiltrates and Spielmeyer coloration for
myelin.
Migration of Th1 Cells in the Brain
C57Bl/6J WT mice were treated intravenously with 30 ng PTX as previously
described (Kerfoot et al., 2004). After 5 hr, 5 3 106 MOG35–55-specific
CFSE-labeled Th1 cells or CFSE-labeled nonantigen-specific Th1 cells were
transferred intomice. CFSE+ cells were detected after 60 hr from brain homog-
enates by flow cytometry analysis.
Immunofluorescence Staining for Confocal Microscopy
This procedure is described in the Supplemental Information.
Statistics
Quantitativedataareshownasmeanvalues±SDorSEM.A two-tailedStudent’s
t test was used for the statistical comparison of two samples. Multiple compar-
isonswereperformedbyone-wayANOVAfollowedbyDunnett’s test formultiple
comparisons. A p value < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and five movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2014.03.004.
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